Literature DB >> 28618843

Risk of cardiac death among cancer survivors in the United States: a SEER database analysis.

Omar Abdel-Rahman1.   

Abstract

BACKGROUND: Population-based data on the risk of cardiac death among cancer survivors are needed. This scenario was evaluated in cancer survivors (>5 years) registered within the Surveillance, Epidemiology and End Results (SEER) database.
METHODS: The SEER database was queried using SEER*Stat to determine the frequency of cardiac death compared to other causes of death; and to determine heart disease-specific and cancer-specific survival rates in survivors of each of the 10 most common cancers in men and women in the SEER database.
RESULTS: For cancer-specific survival rate, the highest rates were related to thyroid cancer survivors; while the lowest rates were related to lung cancer survivors. For heart disease-specific survival rate, the highest rates were related to thyroid cancer survivors; while the lowest rates were related to both lung cancer survivors and urinary bladder cancer survivors. The following factors were associated with a higher likelihood of cardiac death: male gender, old age at diagnosis, black race and local treatment with radiotherapy rather than surgery (P < 0.0001 for all parameters).
CONCLUSION: Among cancer survivors (>5 years), cardiac death is a significant cause of death and there is a wide variability among different cancers in the relative importance of cardiac death vs. cancer-related death.

Entities:  

Keywords:  Cancer; breast cancer; cardiac death; cardiac disease; lung cancer

Mesh:

Year:  2017        PMID: 28618843     DOI: 10.1080/14737140.2017.1344099

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  13 in total

1.  A population-based study of cardiovascular disease mortality risk in US cancer patients.

Authors:  Kathleen M Sturgeon; Lei Deng; Shirley M Bluethmann; Shouhao Zhou; Daniel M Trifiletti; Changchuan Jiang; Scott P Kelly; Nicholas G Zaorsky
Journal:  Eur Heart J       Date:  2019-12-21       Impact factor: 29.983

Review 2.  Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease.

Authors:  Jayakumar Sreenivasan; Urvashi Hooda; Pragya Ranjan; Diwakar Jain
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

3.  Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.

Authors:  Catherine C Coombs; Nancy K Gillis; Xianming Tan; Jonathan S Berg; Markus Ball; Maria E Balasis; Nathan D Montgomery; Kelly L Bolton; Joel S Parker; Tania E Mesa; Sean J Yoder; Michele C Hayward; Nirali M Patel; Kristy L Richards; Christine M Walko; Todd C Knepper; John T Soper; Jared Weiss; Juneko E Grilley-Olson; William Y Kim; H Shelton Earp; Ross L Levine; Elli Papaemmanuil; Ahmet Zehir; D Neil Hayes; Eric Padron
Journal:  Clin Cancer Res       Date:  2018-06-04       Impact factor: 12.531

4.  Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.

Authors:  Charles Dolladille; Stephane Ederhy; Stéphane Allouche; Querntin Dupas; Radj Gervais; Jeannick Madelaine; Marion Sassier; Anne-Flore Plane; Francois Comoz; Ariel Aron Cohen; Franck Roland Thuny; Jennifer Cautela; Joachim Alexandre
Journal:  J Immunother Cancer       Date:  2020-01       Impact factor: 13.751

5.  Increased Risk of Cardiovascular Death in Breast Cancer Patients Without Chemotherapy or (and) Radiotherapy: A Large Population-Based Study.

Authors:  Tianwang Guan; Hanbin Zhang; Jinming Yang; Wenrui Lin; Kenie Wang; Miao Su; Weien Peng; Yemin Li; Yanxian Lai; Cheng Liu
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

6.  Using Shared Medical Appointments for Delivering Patient-Centered Care to Cancer Survivors: A Feist-Weiller Cancer Center Pilot Study.

Authors:  Udhayvir S Grewal; Tyiesha Brown; Ghanshyam R Mudigonda; Cesar Davila-Chapa; Sahith R Thotamgari; Carol Crooms; Jennifer S Singh; Rupa Mahadevan
Journal:  J Patient Exp       Date:  2022-01-13

7.  Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients.

Authors:  Fuhan Yang; Cheng Li; Yadong Guo; Yang Yu; Shiyu Mao; Ruiliang Wang; Wentao Zhang; Aihong Zhang; Xudong Yao
Journal:  Transl Androl Urol       Date:  2021-10

8.  Analysis of Competing Risks of Causes of Death in Cancer Patients from Golestan, Iran over Twelve Years (2004-2016).

Authors:  Mostafa Zare; Susan Hasanpour-Heidari; Shahryar Semnani; Abdolreza Fazel; Seyed Mehdi Sedaghat; Yasamin Semnani; Seyed Mohsen Mansuri; Masoomeh Gholami; Marzieh Araghi; Gholamreza Roshandel
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

Review 9.  Vascular findings on FDG PET/CT.

Authors:  Stephen Liddy; Andrew Mallia; Conor D Collins; Ronan P Killeen; Stephen Skehan; Jonathan D Dodd; Manil Subesinghe; David J Murphy
Journal:  Br J Radiol       Date:  2020-05-06       Impact factor: 3.039

10.  Heart dose linked with cardiac events and overall survival in lung cancer radiotherapy: A meta-analysis.

Authors:  Li Pan; Dengshun Lei; Wenbing Wang; Yanqiu Luo; Dan Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.